First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond

(2017) Naveen Pemmaraju   Current Hematologic Malignancy Reports

Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV)

(2016) Kee K. Yeo et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax

(2016) Joan Montero et al.   Cancer Discovery

Blastic Plasmacytoid Dendritic Cell Neoplasm in the Pediatric Population

(2015) Catherine M. Nguyen et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

(2014) A. E. Frankel et al.   BLOOD

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients

(2013) F. Julia et al.   BRITISH JOURNAL OF DERMATOLOGY

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study

(2013) L. Pagano et al.   HAEMATOLOGICA

Successful treatment of pediatric plasmacytoid dendritic cell tumors with a contemporary regimen for acute lymphoblastic leukemia

(2013) Karen D. Wright et al.   PEDIATRIC BLOOD & CANCER

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

(2012) D. Roos-Weil et al.   BLOOD

Childhood Blastic Plasmacytoid Dendritic Cell Neoplasm Treated with Allogenic Stem Cell Transplantation

(2012) Thilo Gambichler et al.   PEDIATRIC DERMATOLOGY

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

(2010) A. G. Jegalian et al.   HAEMATOLOGICA